Vascular Biogenics Ltd. (VBLT)
Q1 2020 Earnings Conference Call
May 14, 2020 08:30 AM ET
Company Participants
Michael Wood - Investor Relations, LifeSci Advisors
Dror Harats - Chief Executive Officer
Amos Ron - Chief Financial Officer
Conference Call Participants
Jonathan Aschoff - ROTH Capital Partners
Ram Swayampakula - H.C. Wainwright
Sam Slutsky - LifSci Capital
Jonathan Kreizman - Valore Research
Presentation
Michael Wood
Thank you all for participating today's First Quarter 2020 Results and Corporate Update Call for VBL Therapeutics. Leading the call today will be Prof. Dror Harats, CEO; and Amos Ron, the Company’s